Business intelligence reports for the lab diagnostics industry
Subscribe for Exclusive Access.
Subscriptions & Reports
![Mar2022-DTET-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/Mar2022-DTET-Cover.webp)
![March2022-LCA.Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/March2022-LCA.Cover_.webp)
![March2022-LIR-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/March2022-LIR-Cover.webp)
![April-2022-NLR-Briefing-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/April-2022-NLR-Briefing-Cover.webp)
Interested in multiple copies or more than one of our G2 reports?
Call Sokha at 855-528-6903 or email spearson@g2intelligence.com to discuss pricing.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
Analytics Aid Fraud Detection Efforts, Identifying $820 Million in Improper Payments
By Kelly A. Briganti, Editorial Director, G2 Intelligence Analytics aren't valuable just for improving business. The Centers for Medicare and Medicaid Services (CMS) announced this month that its Fraud Prevention System (FPS), an "advanced analytics system," has...
Corporate Wellness Programs Expressing Interest in Genetic Testing
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Nearly half of workers diagnosed with a chronic illness receive their diagnosis through participation in a corporate wellness program, according to survey results recently released by health...
Interleukin, NYU Enter Into Deal to Develop Osteoarthritis Risk Assay
By Ron Shinkman, Editor, Laboratory Industry Report Massachusetts-based molecular laboratory Interleukin Genetics has reached an agreement with the New York University School of Medicine to develop a genetic test that would identify patients at risk for the...
OpGen Agrees to Acquire AdvanDx, Lands $6 Million Investment from Merck
By Stephanie Murg, Managing Director, G2 Intelligence In the wake of its fizzled May IPO, OpGen (Gaithersburg, Md.) is in expansion mode. The microbial genetics analysis company has agreed to acquire molecular diagnostics company AdvanDx (Woburn, Mass.) in an...
Theranos Receives First FDA Clearance, Inks Deal with Capital BlueCross
By Stephanie Murg, Managing Director, G2 Intelligence July is proving to be a month of milestones for Theranos (Palo Alto, Calif.). The company recently received its first FDA clearance—for its herpes simplex virus-1 (HSV-1) IgG assay—and announced a partnership...